Volume 18, Number 5—May 2012
No Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009
|For HIV||Protease inhibitors (J05AE*), nucleoside and nucleotide reverse transcriptase inhibitors (J05AF*), nonnucleoside reverse transcriptase inhibitors (J05AG*), antivirals for treatment of HIV infections, combinations (J05AR*)|
|For influenza||Neuraminidase inhibitors (J05AH*) or cyclic amines (J05AC*)|
|For diabetes||Drugs used in diabetes (A10*), insulins and analogs (A10A*), blood glucose lowering drugs, excluding insulins (A10B*)|
|Immunosuppressants||Antineoplastic agents (L01*), immunosuppressants (L04A*)|
|Systemic antimicrobials||Antibacterials for systemic use (J01*), antimycotics for systemic use (J02*), antimycobacterials (J04*)|
|Systemic steroids||Corticosteroids for systemic use, plain (H02A*), glucocorticoids (H02AB*), corticosteroids for systemic use, combinations (H02B*)|
|Ongoing pregnancy||>1 admission code (O10–16, O20–29, O30–48, O94–99, Z32–36) or >2physician claims (640–649, V22) or >1 tariff code for prenatal services; must be within ±30 d of the index date (26)|
|Completion of pregnancy||>1 admission code (O8, O65–75, O80–84, O85–92, Z37–39) or >2 physician claims (650–659, 670–676) or >1 tariff code for delivery, abortion or postnatal services; must be within 270 d following the index date (26)|
|Alcoholism||>1 admission (E24.4, E51.2, E52, F10, G31.2, G62.1, G72.1, I42.6, K29.2, K70, K86.0, O35.4, P04.3, Q86.0, R78.0, T50.6, T51.0, T51.1, T51.9, X45, X65, Y15, Y57.3, Y90, Y91, Z50.2, Z71.4, Z72.1, Z81.1) or >2 physician claims (291, 303)|
|Anemia||>1 admission (D50–64) or >2 physician claims (280–285)|
|Asthma||>1 admission (J45, J46) or >2 physician claims (493)|
|Cancer, excluding NMS||>1 admission (C00–43, C45–97) or >1 physician claim (140–172, 174–209, 235–239)|
|Cardiovascular disease||>1 admission (I00–99, O11) or >2 physician claims (390–519)|
|Chronic renal failure||>1 admission (I12.0, I13.1, N18, N19, N25.0, Z49, Z99.2) or >2 physician claims (403–404, 586–587)|
|Chronic respiratory condition||>1 admission (J40–99, O24) or >2 physician claims (490–496, 500–508)|
|COPD||>1 admission (J40–44, O24) or >2 physician claims (630–633, 634–639, 490–492, 496)|
|Diabetes||>1 admission (E10–14, G590, G632, H280, H360, M142, M146, N083, O24) or >2 physician claims (250) or >2 prescriptions for drugs used in treatment of diabetes|
|HIV/AIDS||>1 admission (B20–24, R75, Z21) or >2 physician claims (042 V08) or >1 prescriptions for drugs used in treatment of HIV|
|Hypertension||>1 admission (I10–15, I67.4, O11) >2 physician claims (401–405)|
|Immunodeficiency||>1 admission (D80–D84, D89) or >2 physician claims (288, 279)|
|Immunosuppressed||Having an organ transplant or a diagnosis of HIV/AIDS, other immunodeficiency disorders or cancer (other than nonmelanoma skin cancer), or receiving prescriptions for immunosuppressants or systemic steroids|
|Ischemic heart disease||>1 admission (I20–25) or >1 physician claims (410–414)|
|Organ transplant||>1 admission (T86, Y83.0, Z94) or >2 physician claims (V42)|
|Stroke||>1 admission (I61, I63, I64, I67.9, I69) or >2 physician claims (431, 434, 436–438)|
|Substance abuse||>1 admission (F11–16, F18–19) or >2 physician claims (292, 304,305)|
|Area of residence||Based on postal code of current address and the North-South relationship variable derived by using PCCF+#; North includes areas coded as “North” or "North transition"; South includes areas coded as "South" or "South transition"|
*Asterisks indicate a wild-card character used as an alternative to listing all disease or drug codes within a section or subsection of the corresponding classification system.
†TIV, inactivated trivalent influenza vaccine; NMS, nonmelanoma skin cancer; COPD, chronic obstructive pulmonary disease.
‡Drugs were classified based according to their drug identification number and the Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (www.who.int/classifications/atcddd/en/).
§Codes in parentheses are International Classification of Diseases (ICD)-10-CA codes for hospital admission data and ICD-9-CM codes for physician claims data.
¶Based on previously validated chronic disease identification algorithms with modifications.
#Automated Postal Code Conversion File Plus system, Statistics Canada (www.statcan.gc.ca/bsolc/olc-cel/olc-cel?lang=eng&catno=82F0086X).
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: April 05, 2012
- Page last updated: April 05, 2012
- Page last reviewed: April 05, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)